Patients with Alzheimer’s disease may have more bacteria — and different types — in their brains, compared to the general…
Articles by Joana Fernandes, PhD
Pain Therapeutics will soon launch a Phase 1 clinical trial to study the safety and efficacy of PTI-125 in treating Alzheimer’s disease.
A cell death mechanism linked to neuron loss in ALS and stroke also plays a role in neuron loss in…
A poor night’s sleep may increase the levels of proteins associated with Alzheimer’s disease, say researchers, noting that their findings…
An enzyme called asparagine endopeptidase contributes to Parkinson’s as well as Alzheimer’s by slicing off fragments of proteins that end…
A mutation in the BDNF gene can accelerate loss of memory and cognitive function in people at risk of developing…
Alzheimer’s deaths in the United States have jumped more than 50 percent in 15 years, according to the Centers for Disease…
A high-fat, high-sugar diet may increase the risk of Alzheimer’s disease in people carrying the ApoE4 gene, according to a new…
Higher levels of a molecule called anthranilic acid could signal that a person is at increased risk of developing dementia…
Acadia Pharmaceuticals plans to start a Phase 3 clinical program to explore the effect of Nuplazid (pimavanserin) in Alzheimer’s…